.FDA refuses psychedelic MDMA-assisted treatment for PTSD NBC NewsF.D.A. Downtrends to Approve MDMA Therapy, Finding More Study The New York TimesFDA Rejects Ecstasy-Based Medicine The Commercial JournalFDA refuses to approve unfamiliar MDMA treatment to treat post-traumatic stress disorder, with ask for additional litigation information CNNFDA rejects to begin with psychedelic to deal with post-traumatic stress disorder, asking for more study The Washington Message.